Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
JAMA Psychiatry ; 80(5): 409-410, 2023 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-36920375

RESUMEN

This Viewpoint proposes a model of cannabis use disorder diagnosis in the context of cannabis for therapeutic purposes that is based on DSM-5 model of diagnosing substance use disorder in the context of prescribed medication use.


Asunto(s)
Cannabis , Alucinógenos , Abuso de Marihuana , Trastornos Relacionados con Sustancias , Humanos , Abuso de Marihuana/diagnóstico , Trastornos Relacionados con Sustancias/diagnóstico , Agonistas de Receptores de Cannabinoides
2.
Am J Addict ; 31(6): 486-493, 2022 11.
Artículo en Inglés | MEDLINE | ID: mdl-35962766

RESUMEN

BACKGROUND AND OBJECTIVES: While the relationship between recreational cannabis and nicotine use is well established, little is known about nicotine use among users of cannabis for therapeutic purposes (CTP). METHODS: Patients attending a medical marijuana dispensary (N = 697; 75.3% White; 60.0% male) completed a survey examining nicotine use, motivation to quit cigarette smoking, routes of administration of nicotine and cannabis, and CTP qualifying conditions. RESULTS: More than one-third (39.3%) of participants reported current nicotine use. Compared to exclusive cigarette smokers, e-cigarette users and non-users of nicotine were approximately four times more likely to vape, rather than to smoke, cannabis. Furthermore, 46.8% of cigarette smokers reported plans to quit smoking in the next 6 months (but not in the next month) and an additional 31.6% planned to quit in the next month. Having a psychiatric condition was associated with nicotine use and higher motivation to quit smoking. DISCUSSION AND CONCLUSIONS: Users of CTP are more likely to use nicotine products than the general population and the route of administration of nicotine products is related to the route of administration of CTP. If aerosolized CTP is a less harmful route of administration than smoked CTP, dispensary staff should be aware of this relationship and take this into account when recommending a noncombustible route. SCIENTIFIC SIGNIFICANCE: This study further characterizes nicotine use behaviors and motivation to quit smoking among users of CTP and may be among the first to examine nicotine use among patients of a medical marijuana dispensary.


Asunto(s)
Cannabis , Sistemas Electrónicos de Liberación de Nicotina , Alucinógenos , Marihuana Medicinal , Cese del Hábito de Fumar , Productos de Tabaco , Femenino , Humanos , Masculino , Marihuana Medicinal/uso terapéutico , Nicotina , Cese del Hábito de Fumar/psicología , Nicotiana
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA